Amarantus owns 100% of MANF Therapeutics. It's the only subsidiary it owns 100% of. There was no deal for MANF therapeutics to settle debt. You are confusing or misrepresenting something.
(2)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links